Detalhe da pesquisa
1.
Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia.
Bioorg Med Chem
; 56: 116596, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35033885
2.
Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer.
Bioorg Chem
; 117: 105451, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34736137
3.
SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against Gram-negative bacteria.
Eur J Med Chem
; 247: 115040, 2023 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36584632
4.
Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria.
Eur J Med Chem
; 186: 111850, 2020 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31735572
5.
Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors.
Eur J Med Chem
; 155: 316-336, 2018 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29902719
6.
How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors.
Eur J Med Chem
; 142: 131-151, 2017 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28754471